Erratum: Hepatitis B vaccination and multiple sclerosis: A data mining perspective (Pharmaecopidemiology and Drug Safety (2007) vol. 16 (943-945) 10.1002/pds.1420);Hepatitis B vaccination and multiple sclerosis: A data mining perspective [2]

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 8, 2007, Pages 943-945

  Hauben, Manfred ^a,b,c   Sakaguchi, Motonobu ^d   Patadia, Vaishali ^e   Gerrits, Charles M ^e  

^a PFIZER INC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^e TAKEDA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; LEUKOTRIENE RECEPTOR AFFECTING AGENT;

BAYES THEOREM; CAUSAL ATTRIBUTION; CHI SQUARE TEST; CHURG STRAUSS SYNDROME; CONFIDENCE INTERVAL; DATA MINING; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEPATITIS B; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFORMATION PROCESSING; LETTER; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VACCINATION;

EID: 34548226360     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1524     Document Type: Erratum

References (13)

1. Hernan MA, Jick SS. Hepatitis B vaccination and multiple sclerosis: the jury is still out. Pharmacoepidemiol Drug Saf 2005; 15: 653-655.
2. Stricker BH. Pharmacovigilance: a case of phantom ships and Russian roulette. Ned Tijdschr Geneeskd 2002; 146(27): 1258-1261.
3. Hauben M, Reich L, Van Puijenbroek EP, Gerrits CM. Patadia V. Data mining in pharmacovigilance: lessons from Phantom ships. Eur J Clin Pharmacol 2006; 62: 967-970.
4. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4(5): 929-948.
5. Hauben M, Reich L. Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use. Eur J Clin Pharmacol 2005; 61: 479-480.
6. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10(6): 483-486.
7. Szarfman A, Machado SG, O'neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002; 25(6): 381-392.
8. Lindquist M, Stahl M, Bate A, Edwards IR, Meyboomn RH. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf 2000; 23(6): 533-542.
9. Konstantinou D, Paschalis C, Maraziotis T, et al. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clin Infect Dis 2001; 33(10): 1772-1773.
10. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001; 134(4): 330-334.
11. Wald NJ, Morris, JK. Teleoanalysis: combining data from different types of study. BMJ 2003; 327(7415): 616-618.
12. DuMouchel W, Smith ET, Beasley R, et al. Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther 2004; 26: 1092-1104.
13. Harrold LR, Patterson MK, Andrade SE, et al. Asthma drug use and the development of Churg-Strauss syndrome: 2007 (in press).